Effect of Pioglitazone on Cardiovascular Outcome in Diabetes and Chronic Kidney Disease

Patients with diabetes and chronic kidney disease (CKD) are at particularly high risk for cardiovascular disease (CVD). This post hoc analysis from the PROspective pioglitAzone Clinical Trial In macroVascular Events (PROactive) investigated the relationship between CKD and incident CVD in a populati...

全面介绍

Saved in:
书目详细资料
Main Authors: Christian Schneider, Ele Ferrannini, Ralph A. DeFronzo, Guntram Schernthaner, John Yates, Erland Erdmann
格式: Artigo
语言:英语
出版: 2007
在线阅读:https://doi.org/10.1681/asn.2007060678
标签: 添加标签
没有标签, 成为第一个标记此记录!